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1. Introduction 
Hematopoiesis is a tightly regulated process maintained by a small pool of hematopoietic 
stem cells (HSC) capable of undergoing self-renewal and generating mature progeny of all 
of the hematopoietic cell lineages. To sustain the proper levels of blood cells, HSCs must 
continuously monitor and regulate the balance between self-renewal and lineage 
differentiation. To produce all hematopoietic cells, hematopoiesis proceeds in a step-wise 
manner from the primordial long-term (LT)-HSCs. LT-HSCs possess the ability to self-renew 
and the capacity for long-term reconstitution of lethally irradiated hosts. After a first step of 
differentiation, LT-HSCs lose their capacity for self-renewal and give rise to a population of 
short-term (ST)-HSCs. The ST-HSCs has a limited ability to self-renew and reconstitute 
lethally irradiated hosts, but differentiate into a multipotent progenitor (MPP) population. 
The MPPs lack the capacity to undergo self-renewal, but retain multipotency. From these 
multipotent progenitors develops a series of intermediate progenitors that give rise to the 
assorted hematopoietic lineages. In the classical pathway of hematopoiesis, these 
intermediates include the common lymphoid progenitors (CLPs) that differentiate into 
lymphoid, but not myeloid progeny, and the common myeloid progenitors (CMPs), which 
retain full erythromyeloid potential. The CMPs further differentiate to form the 
granulocyte/macrophage progenitors (GMPs) that differentiate to the myelomonocytic 
lineage and the megakaryocytic/erythrocyte progenitors (MEPs) that eventually 
differentiate to form red blood cells and platelets. All these blood cells produced daily in 
high numbers (1 × 1012 cells/day) are derived from a relatively small but rare fraction of 
multipotent cells, the HSCs (Weissman, 2000). 
Transcriptional regulation is a key mechanism controlling HSC homeostasis, development, 
and lineage commitment.  
2. Transcription factors in hematopoietic development   
Hematopoiesis is regulated at the level of pluripotent HSCs and committed progenitors 
through growth and/or differentiation inducing factors (like EPO, G-CSF, GM-CSF, IL-1, IL-
3) that interact with receptors and initiate signal transduction processes that culminate in the 
activation of new genetic programs. These external stimuli trigger intrinsic determinants of 
cell fate, the transcription factors which contribute to the reprogramming of HSCs into cell-
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lineage restricted pathways of maturation (Zon, 2008). Although the transcription factors 
involved in hematopoietic development belong to all classes of DNA-binding proteins some 
of them are involved in the regulation of self-renewal function primarily on HSCs while the 
others act on MPPs and/or early committed progenitors entering the cell-lineage restricted 
pathways of differentiation. While transcription factors as MLL, RUNX1, TEL/ETV6, 
SCL/TAL1 and LMO2 are required for HSC formation and function, others are necessary as 
key lineage restricted factors acting at the level of early pre-committed progenitors, using 
key partners that act synergistically or competing to restrict cell-lineage hematopoietic 
differentiation. GATA-1 and PU-1, for example, physically interact and antagonize with 
each other to promote either myeloid or erythroid maturation (Rekhtman et al., 1999; Zhang 
et al., 1999), which means that suppression of GATA-1 expression favors myeloid 
differentiation while inhibition of PU-1 promotes erythroid maturation. Additional, 
antagonistic interactions with other transcription factors have also been reported as C/EBP 
that antagonizes FOG-1 in eosinophilic differentiation, EKLF antagonizes Fli-1 for erythroid 
versus megakaryocytic differentiation. Finally, repression of the Pax-5 gene prevented Pro-B 
cell maturation to B cells, while promoting multi-potentiality into macrophage, T-NKs and 
dendritic cells (Huntly & Gilliland, 2005). 
Transcription factors also interact with other proteins associated with chromatin 
modification and form active or repressive transcriptional complexes. Knockout of Scl/Tal1 
or Lmo2 abrogates hematopoietic development. The precise mechanism through which such 
transcription activator or repressor complexes regulate the expression of several genes is 
critical, since the gene expression pattern regulates cell fate decision via cell-lineage 
restricted maturation. A critical point, however, for all these transcriptional complexes is the 
concentration of the transcription factor itself and its affinity to other interactive proteins. 
Under normal hematopoiesis, several groups of hematopoietic and mature blood cells are 
generated. Hematopoiesis occurs unidirectionally and commitment from one step to the 
next occurs irreversibly, suggesting that transcription factors regulate cell fate along the 
specific cell-lineage pathways irreversibly. This occurs in such a way because intrinsic 
transcription factor network is coordinated with inputs resulting from external stimuli 
initiated within the hematopoietic cell niche. The question, however, whether one cell type 
of progenitors can be reprogrammed into another phenotype at the level of manipulation of 
transcription factor activation, is a potentially interesting one. Indeed, evidence now 
indicates that transfection of Gata-1 into CMPs and/or CLPs redirects their commitment to 
another cell-lineage restricted pathway as megakaryocytic/erythroid. Similarly, pre-T cells 
can be reprogrammed to myeloid dendritic cells upon PU-1 overexpression (Laiosa et al., 
2006; Orkin & Zon, 2008). 
3. Ontogeny of HSCs 
In vertebrates, the production of blood stem cells is accomplished by the allocation and 
specification of distinct embryonic cells in a variety of sites that change during development. 
In mammals, the sequential sites of hematopoiesis include the yolk sac; an area surrounding 
the dorsal aorta termed the aorta-gonad mesonephros (AGM) region, the fetal liver, and 
finally the bone marrow. Recently, the placenta has been recognized as an additional site 
that participates during the AGM to fetal liver period. The properties of HSCs in each site 
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differ, presumably reflecting diverse niches that support HSC expansion and/or 
differentiation and intrinsic characteristics of HSCs at each stage. For instance, HSCs present 
in the fetal liver are in cycle, whereas adult bone marrow HSCs are largely quiescent.  
The initial wave of blood production in the mammalian yolk sac is termed ‘‘primitive.’’ The 
primary function for primitive hematopoiesis is the production of red blood cells that 
facilitate tissue oxygenation as the embryo undergoes rapid growth. The hallmark of 
primitive erythroid cells is expression of embryonic globin proteins. The primitive 
hematopoietic system is transient and rapidly replaced by adult-type hematopoiesis that is 
termed “definitive”. In mammals, the next site of hematopoietic potential is the AGM 
region. Hematopoietic cells were first detected in the aorta of the developing pig more than 
80 years ago. Morphological examination revealed that a sheet of lateral mesoderm migrates 
medially, touches endoderm, and then forms a single aorta tube. Clusters of hematopoietic 
cells subsequently appear in the ventral wall. Similarly, an intraembryonic source of adult 
HSCs in mice capable of long-term reconstitution of irradiated hosts resides in the AGM 
region (Muller et al., 1994). At embryonic day 10.5, little HSC activity is detectable, whereas 
by day 11 engrafting activity is present. Additional hematopoietic activity in the mouse 
embryo was detected subsequently in other sites, including the umbilical arteries and the 
allantois in which hematopoietic and endothelial cells are co-localized (Inman & Downs, 
2007). Umbilical veins lack hematopoietic potential, suggesting that a hierarchy exists 
during definitive hematopoiesis in which HSCs arise predominantly during artery 
specification. In addition, significant numbers of HSCs are found in the mouse placenta 
(Gekas et al., 2005; Ottersbach & Dzierzak, 2005), nearly coincident with the appearance of 
HSCs in the AGM region and for several days thereafter. Placental HSCs could arise 
through de novo generation or colonization upon circulation, or both. The relative 
contribution of each of the above sites to the final pool of adult HSCs remains largely 
unknown. 
Subsequent definitive hematopoiesis involves the colonization of the fetal liver, thymus, 
spleen, and ultimately the bone marrow. It is believed that none of these sites is 
accompanied by de novo HSC generation. Rather, their niches support expansion of 
populations of HSCs that migrate to these new sites. However, until very recently, there has 
been no evidence by fate mapping or direct visualization that HSCs from one site colonize 
subsequent sites. 
4. Pathways involved in the emergence of HSCs 
The AGM has been characterized largely by morphology and functional assays, but the 
pathways involved in HSC generation remain incompletely defined. Studies of chick 
embryos demonstrate that endoderm has a prominent role and secretes inducing factors. 
Somitic mesoderm also contributes to the dorsal aspect of the aorta, and the addition of 
factors such as VEGF, TGF-ǃ, and FGF to the somitic mesoderm leads to induction of 
hematopoietic tissue. In contrast, TGF-ǂ and EGF suppressed formation of hematopoietic 
cells (Pardanaud & Dieterlen-Lievre, 1999). 
Signaling pathways that regulate the induction of the AGM have been uncovered in mouse 
and zebrafish, Notch 1 is required for artery identity and aortic HSC production (Kumano et 
al., 2003). The fate decisions imposed on mesodermal progenitors within the AGM are 
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clearly influenced by the Notch pathway (Burns et al., 2005). For instance, mice deficient in 
RBPj (a downstream component of the Notch pathway) show expanded VE-Cadherin and 
CD31/PECAM endothelial cell expression with concomitant loss of definitive HSCs (Robert-
Moreno et al., 2005). Ablation of the COUP-TFII transcription factor in endothelial cells 
enabled veins to acquire arterial characteristics, including the expression of Notch1 and the 
formation of ectopic HSCs (You et al., 2005). This result would favor Notch acting to induce 
HSCs from a hemogenic endothelial cell. The model in which the Notch pathway regulates 
arterial and HSC fate choice either from distinct mesodermal populations or over different 
developmental windows since each decision can be uncoupled in vivo is very attractive. The 
finding that both aorta and vein express HSC markers in the Notch-activated state with 
minimal change in ephrinB2a expression indicates that Notch independently regulates 
mesoderm–HSC and artery–vein cell fate decisions.Lateral inhibition has been proposed in 
the central nervous system whereby Notch signaling promotes non-neural fates while 
inhibiting neural development (Lewis, 1998). HSC fate may be established by a similar 
mechanism whereby Notch activation in an endothelial or mesenchymal cell causes down-
regulation of ligand production. Consequently, a cell that produces more ligand will force 
its neighbor to produce less, thus generating a salt-and-pepper pattern of cells containing 
elevated Notch activity. In this model, cells containing high levels of Notch Intra 
Cytoplasmatic Domain (NICD) would become HSCs, while those with low NICD activity 
would remain endothelial or mesenchymal.  
5. Hematopoietic niches 
Stem cells depend on their microenvironment, the niche, for regulation of self-renewal and 
differentiation. As the site of hematopoiesis changes during vertebrate development, the 
nature of the stem cell niche must also change. Mutant mice in which the BMP pathway is 
disrupted have increased numbers of osteoblasts and HSCs (Calvi et al., 2003; Zhang et al., 
2003). These findings suggest that osteoblasts may represent a critical component of the 
bone marrow niche for HSCs. Microscopical examination revealed that HSCs appear to 
reside in the periosteal area of calvarium marrow, where osteoblasts represent an essential 
component of the bone marrow niche (Papadimitriou et al., 1994). Most recent live animal 
tracking experiments by using real-time imaging of individual HSCs have indicated that 
endosteum forms a special zone where HSCs reside (Lo Celso et al., 2009; Xie et al., 2009). 
The bone marrow HSC niche is constituted of mesenchymal cells type osteoblasts, 
extracellular matrix components and minerals (high density calcium salts), all of which 
contribute to the unique micro-environment (niche) (Moore & Lemischka, 2006; Wilson & 
Trumpp, 2006). At least two distinct hematopoietic progenitor cell supportive niches in bone 
marrow have been identified thus far: the osteoblastic, which is regulated by BMP, 
osteopontin, angiopoietin-1, notch and maybe others (Adams & Scadden, 2006; Wilson & 
Trumpp, 2006) and the other one, the vascular niche. The vascular niche is thought to be the 
site where actively dividing stem or progenitor cells is located, and osteoblastic niche is an 
environment promoting maintenance of quiescent HSCs (Calvi et al., 2003). Currently, how 
these two different niches communicate with each other is largely unknown. 
The number of HSCs in the bone marrow niche is highly controlled through physical 
interactions among different cell types, in a way that maintains stem cell state. HSCs remain 
in a quiescent state through close interaction with osteoblasts where this interaction is not 
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only crucial to attach HSCs to niche osteoblasts, but is also essential to maintain HSC 
dormancy and function. Many factors, including ligands for Notch receptors and N-
cadherin, are liberated by osteoblasts, although the contribution of these to adult 
hematopoiesis remains to be established. The role of N-cadherin as a mediator of 
interactions with osteoblasts (Zhang et al., 2003), as well as the prominence of osteoblasts for 
HSC adherence, has been challenged (Kiel et al., 2007).  Recent findings suggest that HSCs 
are maintained in a quiescent state through interaction with thrombopoietin-producing 
osteoblasts (Yoshihara et al., 2007). Thrombopoietin (TPO) is the primary cytokine that 
regulates megakaryocyte and platelet development. Thrombopoietin and its receptor Mpl 
also exert profound effects on primitive hematopoietic cells. All HSCs express Mpl; TPO−/− 
or Mpl−/− mice have a decreased number of repopulating HSCs (Solar et al., 1998). In vitro 
culture studies (Matsunaga et al., 1998) also indicate a role of TPO in promoting the survival 
of repopulating HSCs. Through study of AGM and fetal liver Mpl−/− HSCs, Petit-Cocault et 
al. (2007) showed that TPO contributes to both generation and expansion of HSCs during 
definitive hematopoiesis. An intracellular adaptor, Lnk, induces a negative signaling 
pathway downstream of TPO in HSCs (Buza-Vidas et al., 2006; Seita et al., 2007). Another 
study (Tong et al., 2007) on mice that express Mpl lacking the C-terminal 60 amino acids 
revealed a pivotal role of an unknown signal emanating from the membrane proximal 
region of the Mpl receptor or from JAK2 that is critical for maintenance of HSC activity. 
The association of HSCs with osteoblasts is countered by other studies that place HSCs 
adjacent to vascular cells. The chemokine CXCL12 regulates the migration of HSCs to the 
vascular cells (Kiel & Morrison, 2006). Taken together, these findings suggest that HSCs 
reside in various sites within the marrow and that their function might depend on their 
precise localization. Much of the existing debate may be semantic, however, if the 
osteoblastic and vascular niches are intertwined and not physically separate. Alternatively, 
HSCs may truly reside in distinct sub-regions, which may endow them with different 
activities. Cellular dynamics within the niche are relevant to clinical marrow 
transplantation. For example, recent findings suggest that antibody-mediated clearance of 
host HSCs facilitates occupancy of the niche and transplantation by exogenous HSCs 
(Czechowicz et al., 2007). 
The physical interactions between individual HSCs and osteoblasts may be effective in 
determining the stem cell number by facilitating asymmetric or symmetric divisions, which 
in turn enable HSCs to either self-renew themselves or give birth to early progenitors for 
blood cells production (Moore & Lemischka, 2006; Wilson and Trumpp, 2006). HSCs are not 
of static nature, but exist in a dynamic state, since they migrate from the bone marrow into 
the peripheral blood (frequent trafficking). Whether, or not, HSCs contribute into the repair 
of the vascular system, is still not known (Janzen & Scadden, 2006).  
5.1 Signaling in the niche 
Many cell culture experiments have shown that HSCs respond to multiple cytokines and 
that the fate of a HSC self renewal, apoptosis, mobilization from the niche, formation of 
differentiated progeny cells depends on multiple cytokines, adhesion proteins, and other 
signals produced by stromal cells and likely other cells in the body. Since osteoblast (a cell 
derived from mesenchymal stem cells) is a key component in the HSC niche for the 
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regulation of HSC number via self-renewal (Adams & Scadden, 2006; Huang et al., 2007), 
modifications of osteoblast functions in co-orchestration with other niche components, 
would be pivotal for HSCs survival, self-renewal, differentiation and apoptosis under 
certain circumstances.  
HSCs fate decisions is activated by external environmental stimuli and coordinated by 
intrinsic factors. External stimuli include hematopoietic growth factors such as SCF, 
BMP/TGF-, FGF, TPO, WNT proteins (WNT3A), Angiopoietin-1, IL-3, IL-6, Flt3-ligand, as 
well as Ca2+, hypoxia, PGE2 and retinoic acid (Wilson & Trumpp, 2006) while intrinsic 
factors are essentially genes controlling cell cycle, apoptosis and chromatin remodeling.  
5.2 How some extrinsic factors act in the niche 
Stem cell factor receptor, also known as c-kit and its ligand SCF play a central role in 
hematopoiesis, melanogenesis and gametogenesis (Edling & Hallberg, 2007; Kent et al., 
2008). C-kit is a member of the type-III subfamily of receptor tyrosine kinases that also 
includes the receptor for M-CSF, Flt-3 and PDGF. It is expressed in HSCs (LT-HSCs, ST-
HSCs and MPPs) (Zayas et al., 2008), normal B- and T-cell progenitors, mast cells, germ 
cells, melanocytes, neurons, glial cells, placenta, kidney, lung and gut cells. Deficiency 
and/or deregulation in SCF or c-kit produce defects in hematopoiesis leading to Acute 
Myeloid Leukemia (AML) (Scholl et al., 2008). Sporadic mutations of c-kit and 
autocrine/paracrine activation pathways of the SCF/c-kit pathway have been implicated in a 
variety of malignancies. Gain of function mutations of c-kit are associated with malignancies 
such AML, gastrointestinal tumors and mastocytomas. Moreover, expression of a defective 
c-kit leads to a decrease in repopulating HSCs (Ikuta & Weissman, 1992). 
Binding of SCF to c-kit promotes dimerization and activation of protein kinase that auto-
phosphorylates the receptor. Although SCF may not be essential for the generation of HSCs, 
numerous studies have shown that it prevents HSC apoptosis. Almost all cytokine 
combinations used to date for culturing HSCs include SCF. SCF potentiates the greater 
ability of fetal liver HSCs than adult HSCs to undergo symmetric self-renewal in culture this 
activity likely needs the cooperation of other factors. The membrane-bound form of SCF is 
also an adhesive molecule for HSCs to the bone marrow environment (Heissig et al., 2002) 
as interruption of the interaction between the membrane-bound stem cell factor on 
osteoblasts with the c-kit receptor on HSCs by blocking antibodies has demonstrated that c-
kit signaling is essential to maintain HSC dormancy and function (Suzuki et al., 2006), and 
an increased number of osteoclasts was associated with HSC mobilization. Receptor 
activator of nuclear factor (NF)-κB (RANK) ligand and cathepsin K mediate the cleavage of 
membrane-bound SCF; this decreases the abundance of SCF and, therefore, increases HSC 
mobilization (Kollet et al., 2006). The involvement of SCF in survival, mobility and possibly 
self-renewal of HSCs in culture and in the HSC niche likely reflects the complex relationship 
of different cell fates of HSCs. 
Transforming growth factor (TGF)-ǃ potently inhibits HSC activity in vitro (Blank et al., 
2008). However, a TGF-β signaling deficiency in vivo does not affect proliferation of HSCs. 
TGF-ǃ and BMP are secreted ligands that are recognized by different receptors that 
dimerizes and activates downstream cytosolic targets, culminating with the translocation of 
these activated transcription factors to the nucleus. BMPs, members of the TGF-ǃ 
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superfamily, play important roles in HSC specification during development. A negative role 
of BMP signaling in maintenance of mouse HSCs was shown by its control of the size of the 
HSC endosteal niche (Ross & Li, 2006). BMP4 supports HSC expansion in culture and 
partially mediates the effects of Sonic hedgehog on cultured human HSCs (Bhardwaj et al., 
2001). Recently, expression characterization of TGF-ǃ superfamily ligands, receptors, and 
Smads in mouse HSCs was published; primary HSCs and the Lhx2-HPC cell line express 
most of the proteins required to transmit signals from several TGF-ǃ family ligands 
(Utsugisawa et al., 2006). In addition, Pimanda et al. (2007) demonstrated the integration of 
BMP4/Smad pathway and Scl and Runx1 activity in HSC development.  
All long-term repopulating bone marrow HSCs express a fibroblast growth factor (FGF) 
receptor (Yeoh et al., 2006); both FGF-1 and FGF-2 support HSC expansion when 
unfractionated mouse bone marrow cells are cultured in serum-free medium. Crcareva et al. 
(2005) confirmed that FGF-1 stimulates ex vivo expansion of HSCs and showed that the 
expanded cells were efficiently transduced by retrovirus vectors. Conditional derivatives of 
FGF receptor-1 have also been used to support short-term HSC expansion and long-term 
HSC survival in culture (Schiedlmeier et al, 2007). However, the role of the FGF pathway in 
regulating adult HSCs or embryonic hematopoietic development is controversial as the 
same authors showed that the treatment of purified mouse HSCs that ectopically express 
HoxB4 with the fibroblast growth factor receptor (FGFR) inhibitor SU5402 enhanced HSC 
repopulating activity. Similar results were obtained using primitive hematopoietic colonies 
derived from embryonic stem cells. These inconsistent results were obtained from different 
starting cell populations and under different culture conditions, suggesting that the 
crosstalk of FGF signaling with other pathways is complex. 
The WNT protein binds to a receptor complex consisting of a member of the Frizzled family 
of seven transmembrane proteins and the LDL receptor-related proteins LRP5 or LRP6 
(Clevers, 2006). In the canonical Wnt pathway, receptor activation leads to stabilization of β-
catenin, which accumulates and translocates to the nucleus where it activates target gene 
expression in concert with transcription factors such as TCF and LEF. Fleming et al. (2008) 
analyzed the role of Wnt signaling on HSC activity, including its effects on cell-cycle 
quiescence and the capacity of HSCs to reconstitute the hematopoietic system of recipient 
mice (whose bone marrow has been ablated by radiation). In contrast to previous studies 
that genetically manipulated the HSCs themselves, they analyzed the effects of blocking 
Wnt signaling in the mouse bone marrow microenvironment by overexpression of 
dickkopf1 (Dkk1), an antagonist of Wnt/ β-catenin signaling. Dkk1 is a soluble secreted 
protein that interacts with the Wnt co-receptors LRP5 and LRP6 (Kawano & Kypta, 2003). It 
is known that the number of osteoblasts directly affects the number of long-term 
repopulating HSCs (Calvi et al., 2003; Zhang et al., 2003). The overexpression of Dkk1 in the 
osteoblastic lineage under the control of a 2.3 kb fragment of the collagen 1ǂ promoter 
reduced activation of the Tcf/Lef transcription factors in HSCs in a non-cell-autonomous 
manner. 
The transgenic mice showed no significant alteration in the proportion of HSCs and 
common lymphoid progenitor cells under steady-state conditions. Although HSCs from the 
Dkk1 transgenic mice could reconstitute the hematopoietic system of irradiated recipient 
mice, they lost their reconstituting capacity after repeated bone marrow transplantation, 
indicating that the inhibition of Wnt signaling in the niche results in the premature loss of 
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self-renewal activity. These findings show that Wnt/β-catenin activity is crucial for the 
maintenance of HSC quiescence in the bone marrow niche. 
The angiopoietin (Ang) family of growth factors is composed of four members that bind to 
the Tie-2 tyrosine kinase receptor; Ang growth factors are important modulators of 
angiogenesis. Members of the angiopoietin family of proteins contain an N-terminal coiled–
coil domain that mediates homo-oligomerization and a C-terminal fibrinogen-like domain 
that binds Tie-2. To identify the HSCs in situ, Arai et al. (2004) analyzed the receptor 
tyrosine kinase Tie-2 expression in bone marrow and found that 5-FU-resistant Tie-2 
expressing HSCs adhere to osteoblasts at the endosteal surface, in agreement with previous 
findings of Calvi et al. (2003) and Zhang et al (2003). They also demonstrated that 
angiopoietin-1 (Ang-1), a Tie-2 receptor ligand, is produced primarily by osteoblasts, 
indicating that Tie-2 and Ang-1 are expressed complementarily in the niche. Tie-2 together 
with Tie-1 was also found required for homing of HSCs to bone marrow. Taken together, 
Tie receptors seem one group of the likely candidates for localizing stem cells to the stem 
cell niche. 
Mineral content of bone contributes to compose a unique extracellular matrix in bone 
marrow and distinguishes it from other mesenchymal tissues. The extracellular calcium 
concentrations are recognized by the seven-transmembrane calcium-sensing receptors and 
therefore can initiate an intracellular G protein–coupled response. Those receptors are found 
on hematopoietic cells and have also been identified on the surface of HSCs (Adams et al., 
2006). Local calcium gradient is involved in retaining HSCs in close physical proximity to 
the endosteal surface of bone. Extracellular calcium ion concentrations in the endosteum are 
likely higher than in the central marrow region (Silver et al., 1988). In receptor deficient mice 
models, HSCs were found not to engraft in the bone marrow (Adams et al., 2006) suggesting 
that the ability of stem cells to sense and respond to the increased calcium concentrations at 
the endosteal surface participates in creating the unique stem cell-niche interaction that 
enables bone marrow hematopoiesis. 
Most slow-cycling hematopoietic cells are found in the hypoxic zones close to bone surface 
and distant from capillaries (Kubota et al., 2008), raising the possibility that these hypoxic 
niches are important for diminished HSC proliferation. Evidence for quiescent HSCs 
situated in a hypoxic environment has lately been confirmed by analyzing bone marrow 
cells from mice injected with a Hoechst dye. Transplantation results showed that the bone 
marrow fraction with the lowest Hoechst-dye uptake, inferred to be hypoxic, had the 
highest amount of long-term repopulating cells (Parmar et al., 2007). Consistently, HSCs 
were found to be the most positive for binding of the hypoxic probe pimonidazole. The 
molecular mechanisms involve the hypoxia-inducible factor-1a regulated gene expressions 
in stromal cells, such as c-Kit, stromal cell derived factor−1, and others (Ceradini et al., 
2004). 
Other molecules were recently identified to have role in signaling pathways inside the 
niche. DNA array experiments showed that, among other proteins, IGF-2 is specifically 
expressed in cells that do support HSC expansion in culture. Moreover, it was showed that 
all fetal liver and bone marrow HSCs express receptors for IGF-2.  The inclusion of IGF-2 
with SCF, TPO, and FGF-1 supports an eight-fold increase of highly enriched HSCs in 
culture (Zhang & Lodish, 2004). Whether IGF-2 acts on self-renewal, apoptosis, 
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differentiation, or homing of HSCs is unclear. Interestingly, IGF-2 was found to bind and 
stimulate self-renewal of human embryonic stem cells (Bendall et al., 2007). Angiopoietin-
like proteins (Angptls) were also implicated in HSC expansion. Angptls are a family of 
seven secreted glycoproteins that share sequence homology with the angiopoietins 
(Morisada et al., 2006). Similar to the angiopoietins, each Angptl contains an N-terminal 
coiledcoil domain and a C-terminal fibrinogen-like domain. However, unlike angiopoietins, 
Angptls do not bind to Tie-2 or Tie-1 and their receptors are unknown. This suggests that 
Angptls may have different functions from the angiopoietins. Angptl7 was suggested to be a 
target of the Wnt/β-catenin signaling pathway. However, most of the physiological activities 
of the Angptls remain unknown. Recently Angptl2 and Angptl3 were identified as growth 
factors that stimulate ex vivo expansion of bone marrow HSCs. Other analogues, including 
Angptl5, Angptl7, and Mfap4, also support ex vivo expansion of HSCs.  
5.3 Signaling through cell adhesion molecules 
In addition to signaling pathways as described above, extracellular matrix components of 
the niche have also been shown to play role in regulating the HSC dynamics. A matrix 
glycoprotein, osteopontin (OPN), as a constraining factor on HSCs within the bone marrow 
microenvironment is produced by osteoblasts in response to stimulation (Stier et al., 2005). 
Using studies that combine OPN-deficient mice and exogenous OPN, Stier et al. (2005) 
demonstrated that OPN modifies primitive hematopoietic cell number and function in a 
stem cell non-autonomous manner. The OPN-null microenvironment is sufficient to increase 
the number of stem cells associated with increased stromal Jagged-1 and Ang-1 expression 
and reduced primitive hematopoietic cell apoptosis. The activation of the stem cell 
microenvironment with PTH was shown to induce a super-physiologic increase in stem cells 
in the absence of OPN. Therefore, OPN seems to be a negative regulatory element of the 
stem cell niche that limits the size of the stem cell pool and may provide a mechanism for 
restricting excess stem cell expansion under conditions of niche stimulation. 
The production of OPN by osteoblasts is likely to be an essential requirement as shown by 
Karahuseyinoglu et al. (2007). Osteogenically induced umbilical cord stromal cells express 
OPN during the first week of induction followed by a third week expression of another 
matricellular protein, bone sialoprotein-2 (BSP-2). In the following weeks, in conditioned 
media differentiating osteoblasts express osteonectin and osteocalcin that led us to suggest 
that all those proteins have roles in autocrine regulation of osteoblast maturation and thus 
might serve to determine the conditional status of the partner cell(s) in hematopoietic niche 
microenvironment.  
Previous studies showed that cell adhesion molecules, such as cadherins and integrins, are 
crucial for the interactions between HSCs and the osteoblastic niche. N-cadherin−mediated 
adhesion mediates slowing cell cycling of HSCs and may keep HSCs quiescent. Some 
studies showed that specialized spindle-shaped N-cadherin+ osteoblasts are a key 
component of the bone marrow stem cell niche. HSCs are thought to be anchored to spindle-
shaped N-cadherin+ osteoblast cells via a homotypic N-cadherin interaction. Also, N-
cadherin and ǃ1-integrin are identified as the downstream targets in Tie-2/Ang-1 signaling 
and TPO/MPL signaling (Yoshihara et al., 2007) in HSCs, respectively, suggesting a link 
between adhesion molecules and cell-cycle regulators in modulating the HSC−niche 
interaction. These data suggest cell-adhesion molecules not only contribute to the anchoring 
www.intechopen.com
 Advances in Hematopoietic Stem Cell Research 
 
12
of HSCs to the niche, but also regulate cell-cycle quiescence of HSCs in the niche. However, 
the studies by conditional deletion of N-cadherin fail to support the effects of N-cadherin on 
hematopoiesis (Kiel et al., 2007). 
The members of the Notch family are developmental morphogens shown to be expressed in 
self-renewing tissues, enhance the self-renewal capacity of HSCs and promote T-cell 
differentiation. Notch signaling is initiated by the involvement of the extracellular portion of 
Notch with its ligands Jagged/Delta. Activation of the Notch signaling pathway has been 
shown to potentiate self-renewal of HSCs. It is initiated by the binding of Jagged ligand to 
Notch protein followed by metalloproteinase (-secretase) cleavage in the extracellular 
receptor portion leading to the intracellular release of Notch (NICD). Then Notch translocate 
into the nucleus, where it forms a multimeric transcriptional complex with other 
transcription factors (Huntly & Gilliland, 2005). Inhibitors of -secretase abrogate the Notch 
signaling activation (Rizzo et al., 2008; Shih & Wang, 2007). 
Calvi et al. (2003) and Duncan et al. (2005) demonstrated that the Notch signaling pathway 
plays a role in the osteoblast bone marrow HSCs niche. Notch ligands have positive effects 
on ex vivo expansion of HSCs: activated Notch is able to immortalize primitive mouse 
hematopoietic progenitors and Notch ligands support HSC expansion in culture (Chiba, 
2006). Recently, by culturing human cord blood cells in serum-free medium supplemented 
with SCF, TPO, Flt3L, IL-3, IL-6/sIL-6R, and Delta 1, Suzuki et al. (Suzuki et al., 2006) 
reported an approximate six-fold increase in SCID-repopulating cell (SRC) number. It is 
noteworthy that there exists a dose effect for Notch ligands in HSC culture. Whereas a low 
amount of Delta 1 supports human cord blood SRC expansion, high amounts of the cytokine 
induce apoptosis (Chiba, 2006). 
This emphasizes the complicated relationship among the different fates of HSCs. As 
conditional knockouts of Notch1 and Jagged1 have normal in vivo HSC activities (Mancini et 
al., 2005), there likely is functional redundancy of different Notch isoforms and their ligands. 
Endothelial cells in the vascular niche environment contacting HSCs also provide 
maintenance signals on the HSC behaviour (Coultas et al., 2005 ; Li & Li, 2006). The main 
components of vascular niche – hematopoietic cells and endothelial cells – are closely 
related during development since they are both derived from haemangioblasts (Kopp et 
al., 2005). Previous studies have suggested that the vascular niche is the place for HSC 
differentiation and mobilization (Avencilla et al., 2004). Endothelial cells expressing 
vascular cell-adhesion molecule-1 (VCAM-1) associate closely with megakaryocytes and 
their progenitors through VLA-4 in response to chemotactic factors, stromal cell-derived 
factor- 1 (SDF1) and fibroblast growth factor-4 (FGF4), and thus provide a niche for 
megakaryocyte maturation and platelet production. The immediate juxtaposition of 
HSCs to endothelial cells also facilitates their rapid mobilization and entry into 
circulation in response to stress and, in the case of megakaryocytes, release of platelets 
directly into the blood. Endothelial cells promote survival of HSCs in culture, but this 
seems to be limited to certain populations of endothelial cells (Li et al., 2004). Fractions of 
HSCs in both adult bone marrow and spleen were found in close association with 
endothelial sinusoids (Kiel et al., 2005), suggesting that endothelial cells provide support 
to HSCs in vivo. Depending on these data, it is now plausible to note that while the 
osteoblastic niche provides a quiescent environment for HSC maintenance, the vascular 
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niche offers an alternative niche for mobilized stem cells and promotes proliferation and 
further differentiation or maturation into the circulatory system. It would be interesting 
to further define the respective contributions of endothelial and endosteal niches to HSC 
behaviour. 
5.4 Cell intrinsic responses 
Recent studies have shown that Polycomb group (PcG) proteins and their interaction are 
important in the regulation of HSC self-renewal and lineage restriction. In particular, 
members of the PRC1 (Polycomb repression complex 1), such as Bmi1, Mel18 and Rae28, 
have been implicated. Bmi1 plays an important role in regulating the proliferative activity 
of stem and progenitor cells. It is required for the self-renewal of both adult HSCs and 
neural stem cells (Molofsky et al., 2005; Park et al, 2003). Bmi1 enhances symmetrical 
expansion of the stem cell pool through self-renewal, induces a marked ex vivo expansion 
of multipotent progenitors, and increases the ability of HSCs to repopulate bone marrow 
in vivo (Iwama et al., 2004). Leukemic cells lacking Bmi1 undergo proliferation arrest, 
differentiation and apoptosis, leading to failure of leukemia in a mouse transplant model 
(Lessard & Sauvageau, 2003). In Bmi1-deficient bone marrow there is an up-regulation of 
cell cycle inhibitors p16 and p19, and the p53-induced gene Wig1, and a down-regulation 
of the apoptosis inhibitor AI-6. This suggests that a mechanism exists whereby Bmi1 
functions by modulating proliferation and preventing apoptosis (Park et al., 2004). Bmi1 
has also been shown to regulate the expression of Hox genes that are required for 
differentiation during hematopoiesis (van der Lugt et al., 1996).Loss or knockdown of 
another Polycomb gene, Mel18, leads to increased expression of Hoxb4 (Kajiume et al., 
2004), and transplanted Mel18-deficient bone marrow showed an increase in overall HSC 
numbers but a decrease in their activity owing to arrest in G0 phase of the cell cycle. 
Rae28-deficient HSCs were defective in their long-term repopulating ability in serial 
transplantation experiments (Kim et al., 2004; Ohta et al., 2002). Taken together, these 
studies show the importance of the Polycomb proteins in HSC self-renewal and 
maintenance of the blood system. 
Transcriptional repression by PcG proteins is essential for maintenance of HSC identity. Part 
of the mechanism by which it functions is by repression of genes that promote lineage 
specification, cell death and cell cycle arrest. More recently, PcG complexes have been 
shown to be essential for maintenance of the undifferentiated state in murine embryonic 
stem (ES) cells and human ES cells by directly repressing a large number of developmental 
regulators (Boyer et al., 2006; Lee et al., 2006). PcG complexes bind to and presumably 
repress the expression of a subset of these genes linked to differentiation. This represents a 
dynamic repression of genes required for differentiation, and a scenario in which PcG 
proteins act as transcription repressors by cooperating with a specific set of transcription 
factors in stem cells. Some target genes include Hox family members important for induction 
of differentiation. Expression of Hox genes that are involved in differentiation is repressed in 
the ES cells by PcG proteins. Thus, PcG complex repression is also necessary for ES cell 
identity. Taken together, these studies suggest that differentiation is the default state during 
stem cell replication, and self-renewal requires active repression of transcription factors that 
prevent self-renewal 
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The transcription factor Tel (Translocation Ets leukemia; also known as Etv6 [Ets variant 
gene 6]), an Ets (E-26 transforming-specific)-related transcriptional repressor, is also 
required for HSC maintenance. Conditional inactivation of Tel/Etv6 in HSCs rapidly leads to 
the depletion of Tel/Etv6-deficient bone marrow. However, Tel/Etv6 is not required for the 
maintenance of committed precursors. When it is conditionally inactivated in most 
hematopoietic lineages, it does not affect their differentiation or survival (Hock et al., 2004). 
At the moment, the mechanism by which Tel/Etv6 modulates adult HSCs renewal is not 
known. Study of the downstream targets it represses should shed light on other players 
essential for HSC maintenance. 
Pbx1 (pre–B-cell acute lymphoblastic leukemia) is a TALE class homeodomain transcription 
factor that critically regulates numerous embryonic processes, including hematopoiesis. 
Pbx1 is preferentially expressed in LT-HSCs compared to more mature short-term HSCs and 
multipotent progenitor cells (Ficara et al., 2008). By using Pbx1-conditional knockout mice, it 
was revealed that Pbx1 positively regulates HSC quiescence. Transcriptional profiling 
showed that a significant proportion of Pbx1-dependent genes are associated with the TGF-β 
pathway. 
The homeobox (Hox) genes encode transcription factors that regulate embryonic body 
patterning and organogenesis. They play a role in the regulation of hematopoiesis. 
Overexpression of HoxB4 in bone marrow leads to expansion of HSCs in vivo and in vitro, 
therefore appearing to be a positive regulator of HSC self-renewal (Antonchuck et al., 2002; 
Krosl et al., 2003; Miyake et al., 2006; Sauvageau et al., 1995). It therefore came as a surprise 
when HoxB4-deficient mice had normal hematopoietic development but exhibited only mild 
proliferative HSC defects (Brun et al., 2004). In an attempt to determine if this was due to 
compensatory mechanisms, the entire HoxB cluster was deleted. However, this did not lead 
to major defects in hematopoiesis (Bijl et al., 2006), possibly owing to compensation by 
HoxA4 and/or HoxC4. 
Gfi1 (Growth factor independence 1), a zinc-finger repressor, has been recently implicated as 
a regulator of HSC self-renewal. Two groups working independently determined that Gfi1 
controls self-renewal of HSCs by restraining their proliferative potential (Hock et al 2004; 
Zeng et al., 2004). They showed that Gfi1-deficient HSCs display increased proliferation 
rates and are also functionally compromised in competitive repopulation and serial 
transplantation assays. Gfi1 might exert its effects on HSC proliferation by regulating the 
cell cycle inhibitor p21.  
Gfi1 is originally recognized for its role in T-cell differentiation and lymphoma. Gfi1 gene 
knockout is one of the first targeted mutants to exhibit the combination of an increase in 
cycling HSCs at the expense of HSC function. Both Gfi1 knockout models displayed an 
increase in cycling cells within the HSC pool, a large decrease in HSC function in 
transplantation experiments. Profoundly reduced expression of p21, the cyclin-dependent 
kinase inhibitor, in Gfi1 null HSCs may account for the mechanism. Thus, under normal 
homeostasis, Gfi1 is thought to suppress the proliferation of HSCs, thereby keeping HSCs in 
quiescence. 
Numerous studies have identified roles for p53 in the proliferation, differentiation, 
apoptosis, and aging of hematopoietic cells. LT-HSCs express high levels of p53 transcripts, 
which is an indication of roles of p53 in HSC physiology (Dumble et al., 2007). Recently, p53 
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has been identified as a positive regulator of HSC quiescence through analysis of p53−/− 
mice (Liu et al., 2009). Furthermore, in the same study, it was demonstrated that the 
increased quiescence of HSCs from MEF null mice, in which both p53 and p21 are up-
regulated, is dependent on p53, but not p21, further confirming the positive role of p53 in 
maintaining HSC in quiescence. Gfi1 was identified as p53 target gene, which is both shown 
important in regulating HSC quiescence by up-regulation or knockdown experiments. 
Stem cell leukemia/T-cell acute lymphoblastic leukemia 1 (SCL/TAL1) plays a key role in 
controlling development of primitive and definitive hematopoiesis during mouse 
development. In adult HSCs, it is highly expressed in LT-HSCs compared with short-term 
HSCs and progenitors (Lacombe et al., 2010). SCL impedes G0-G1 transition in HSCs. The 
function of HSCs from Scl +/− mice or with decreased dosage of SCL protein by in vitro 
interference was shown decreased in various transplantation assays. At the molecular level, 
SCL maintains HSC quiescence by regulating gene expression of Cdkn1a and Id1. 
Recently, many other transcriptional factors, such as interferon regulatory factor−2, a 
transcriptional suppressor of interferon signaling (Sato et al., 2009); Nurr1, a nuclear 
receptor transcription factor (Sirin et al., 2010); and thioredoxin-interacting protein, a 
transcriptional repressor (Shao et al., 2010), have been identified as positive regulators of 
HSC quiescence. Loss of HSC quiescence was observed in mice with deletion of each of 
these factors. 
Individual member of Retinoblastoma (Rb) tumor suppressor gene family serves critical 
roles in the control of cellular proliferation and differentiation with functional redundancy 
for each other. The mice with conditional triple knockout of Rb family genes including Rb, 
p107, and p130 display a cell-intrinsic myeloproliferation that originates from 
hyperproliferative early hematopoietic progenitors due to the loss of quiescence, and the 
mutant HSCs show strong short-term repopulation capacity but impaired long-term 
repopulation ability on transplantation. Thus, Rb family members collectively maintain HSC 
quiescence (Viatour et al., 2008). 
It has been shown that the conditional inactivation of c-Myc induces excessive expression of 
integrins and N-cadherin in HSCs, leading to the enhanced HSC interaction with the niche, 
which subsequently enable Myc-deficient HSCs stay in quiescence. Conversely, enforced c-
Myc expression in HSCs downregulates N-cadherin and integrins, leading to a loss of HSC 
function (Wilson et al., 2004). 
p21 mRNA expression levels are dramatically lower in the Gfi1-deficient HSCs. p21  itself 
has been implicated in the regulation of HSCs (Cheng et al., 2000). In its absence, HSCs have 
an impaired serial transplantation capacity. Another cell cycle inhibitor, p18 , has also been 
shown to affect HSC self-renewal. The absence of p18 leads to increased HSC self-renewal 
(Yuan et al., 2004; Yu et al., 2006). Therefore, intricate control of the cell cycle and 
proliferation machinery is required for self-renewal regulation. 
In contrast to p21, little is known about the role of p57 in adult stem cell populations. Using 
primary human hematopoietic cells and microarray analysis, Scandura et al. (2004) 
identified p57 as the only cyclin-dependent kinase inhibitor induced by TGF-ǃ. Up-
regulation of p57 is essential for TGF-ǃ−induced cell-cycle arrest in these cells, which may 
represent the mechanisms by which TGF-ǃ affects cell-cycle arrest and stem cell quiescence. 
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Bone marrow is a very low oxygen tension environment that would protect cells from 
exposure to oxidative stress. Various intrinsic factors have also been identified to function in 
maintaining low oxidant levels in HSCs. ATM, a cell-cycle checkpoint regulator activated 
after DNA damage, is shown to regulate oxidant levels in HSCs (Ito et al., 2006). ATM 
deficiency-induced ROS elevation in HSCs specifically activates the p38 mitogen-activated 
protein kinase (MAPK) pathway, a signaling pathway responding to diverse cellular 
stresses, leading to a defect in the maintenance of HSC quiescence (Ito et al., 2004). ATM−/− 
mice over the age of 24 weeks show progressive bone marrow failure due to a defect in HSC 
function associated with elevated levels of ROS. Treatment with anti-oxidative reagents, N-
acetyl cysteine or with a MAPK inhibitor restores reconstitutive capacity and quiescence of 
ATM−/− HSCs. 
Members of the FoxO subfamily of forkhead transcription factors have been shown to 
protect HSCs from oxidative stress by up-regulating genes involved in their detoxification. 
Triple knockout mice of FoxO1, FoxO3, and FoxO4 exhibited defective long-term 
repopulating activity of HSCs, which correlated with increased cycling and apoptosis of 
HSCs, as well as increased levels of ROS in HSCs (Tothova et al., 2007). Similarly, the HSC 
compartment in FoxO3a null mice suffers from augmented levels of ROS and subsequent 
bone marrow failure (Miyamoto et al., 2007). The HSC defect resulting from loss of FoxOs 
could also be rescued by administration of the antioxidant N-acetyl cysteine. 
It is conceivable that both the hypoxic environment in which the HSCs reside and the 
intrinsic factors in HSCs serve to protect HSCs from oxygen radicals, keeping HSCs’ 
quiescent status. 
The JAK–STAT (Janus family kinase–signal transducer and activator of transcription) 
pathway is a common downstream pathway of cytokine signaling that promotes 
hematopoiesis. Constitutive activation of the transcription factors of the Stat family, 
particularly Stat3 and Stat5, are frequently detected in leukemias, lymphomas and solid 
tumors. In order to evaluate their role in HSCs, constitutively active Stat mutants were 
used to activate signaling in HSCs. Activation of Stat5 in HSCs led to the dramatic 
expansion of multipotent progenitors and promoted HSC self-renewal ex vivo (Kato et al., 
2005). Deletion of Stat5 resulted in profound defects in hematopoiesis and markedly 
reduced ability of the mutant cells to repopulate the bone marrow of lethally irradiated 
mice (Snow et al., 2002). In a mouse model of myeloproliferative disease (MPD), sustained 
Stat5 activation in HSCs and not multipotent progenitors induced fatal MPD, suggesting 
that the capacity of Stat5 to promote self-renewal of hematopoietic stem cells is crucial for 
MPD development. Another group showed that transduction of adult mouse bone 
marrow cells with a constitutively activated form of Stat3 increased their regenerative 
activity in lethally irradiated recipients, whereas the transduction of these cells with a 
dominant negative form of Stat3 suppressed their regenerative activity (Chung et al., 
2006). These studies suggest that Stat proteins play a role in HSC self-renewal and 
potentially in other tissues; owing to the wide range of solid tissue and blood 
malignancies that harbor constitutively activated Stats. 
Studies using transgenic mice constitutively expressing BCL2 (B-cell lymphoma 2) in all 
hematopoietic tissues provide evidence directly supporting this theory. The forced 
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expression of the oncogene Bcl2 resulted in increased numbers of transgenic HSCs in vivo 
and gave these cells a competitive edge over wild type HSCs in competitive reconstitution 
experiments (Domen et al., 1998; Domen et al., 2000) suggesting that cell death plays a role 
in regulating the homeostasis of HSCs. Recently, Mcl1 (Myeloid cell leukemia 1), another 
anti-apoptotic Bcl2 family member, has been shown to be required for HSC survival 
(Opferman et al., 2005). 
6. Quiescence or self-renewal 
In order to both maintain a supply of mature blood cells and not exhaust HSCs throughout 
the lifetime of an individual, under steady state, most HSCs remain quiescent and only a 
small number enter the cell cycle. However, in response to hematopoietic stress such as 
blood loss, HSCs exit quiescence and rapidly expand and differentiate to repopulate the 
peripheral hematopoietic compartments. When quiescence is disrupted, HSCs displayed 
defective maintenance in G0 phase of cell cycle, leading to premature exhaustion of the stem 
cell pool under conditions of hematopoietic stress, impaired self-renewal, and loss of 
competitive repopulating capacity, eventually causing hematological failure. 
Quiescence of HSCs is not only critical for protecting the stem cell compartment and 
sustaining stem cell pools over long periods, but it is also critical for protecting stem cells by 
minimizing their accumulation of replication-associated mutations. The balance between 
quiescence and proliferation is tightly controlled by both HSC-intrinsic and -extrinsic 
mechanisms. Understanding quiescence regulation in HSC is of great importance not only 
for understanding the physiological foundation of HSCs, but also for understanding 
the pathophysiological origins of many related disorders. 
In steady state conditions HSCs are in a slowly dividing state, termed relative quiescence, 
with a cell division cycle in the mouse in the range of 2–4 weeks, localized in close contact 
with stromal cells, including osteoblasts (Calvi et al., 2003; Zhang et al., 2003).  This is in 
contrast to the rapidly cycling hematopoietic progenitor cells, which are more committed to 
differentiation than HSCs. The balance between quiescent and cycling stem cells was 
proposed to rely on the amount of soluble cytokines, which result in HSCs relocating from 
the osteoblastic to the vascular niche (Heissig et al., 2002). However new results indicate that 
it depends on a complex network of signals.  
 
Fig. 1. Networks interaction model for: A) quiescence, B) self-renewal and C) survival. 
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In part, the dramatic contrast in cell cycle status between stem and progenitor cells has led 
to the hypothesis that cell cycle regulation plays a fundamentally important role in stem cell 
fate determination. This hypothesis is supported by recent data demonstrating a slower rate 
of division in Hoxb4hiPbx1lo cells, which extensively self-renewal in vitro, compared to 
control cells (Cellot et al., 2007). It is essential for an HSC to undergo cell division if it is to 
self-renew, but how the cell division cycle is integrated into the process of self-renewal is 
unclear. It is also unknown as to whether cell cycle regulation represents an intrinsic or 
extrinsic modifier of HSC fate. 
6.1 How HSC maintain quiescence  
Negative regulators of both Cdk2 and Cdk4/6 activity, and therefore Rb function, have been 
demonstrated to have roles in regulating HSCs (Cheng et al., 2000; Janzen et al., 2006; 
Stepanova & Sorrentino, 2005; Van Os et al., 2007; Walkley et al., 2005). For the most part 
however these phenotypes have been relatively subtle, particularly when compared to 
hematopoietic phenotypes apparent after disruption of transcription factors such as C/EBPǂ  
(Hock et al., 2004) and Tel  (Zhang et al., 2004) amongst others, and are often apparent only 
after serial transplantation. The "Rb pathway" has also been implicated in phenotypes 
observed in both the Bmi1-/- and ATM-/- HSCs (Ito et al., 2004; Lessard & Sauvageau, 2003; 
Park et al., 2003).  The interaction of cell cycle regulators with other factors such as Hoxb4 or 
telomerase deficiency has produced much more striking phenotypes than that observed for 
the cell cycle mutants in isolation (Choudhury et al., 2007; Miyake et al., 2006). While clearly 
demonstrating that cell cycle modifiers have roles in regulating stem cells, particularly 
HSCs, the aforementioned studies have not been able to clearly discriminate between 
intrinsic or extrinsic contributions to HSC fate as all studies to date had utilized non-
hematopoietic restricted mutant alleles. A study demonstrating that the p27Kip1-/- 
microenvironment mediates the myelo-lymphoid expansion observed in the p27Kip1-/- 
animals raises the possibility that the HSC expansion observed in p27Kip1-/- bone marrow is 
extrinsic in nature (Chien et al., 2006; Walkley et al, 2005). This result suggested that cell 
cycle regulators might play a role in regulating the competence of the hematopoietic niche, 
in addition to having potential intrinsic roles in HSC fate determination. Moreover Daria et 
al (2007) observed a requirement for Rb in the stress response of HSCs and this has also 
previously been suggested in the context of the role of Rb in erythropoiesis (Spike et al., 
2004; Spike & Macleod, 2005). 
Also of note is that the cell division dynamics of HSCs change during development, from 
rapidly cycling and dividing cells during the fetal liver and early stages of life to relatively 
quiescent and more slowly cycling in the adult context (Bowie et al., 2007; Bradford et al., 1997; 
Ito et al, 2000; Kiel et al., 2007; Sato et al., 1999). Thus the role for Rb may be context dependent, 
both in terms of stress response and developmentally in the regulation of HSC fate. 
One important point that is becoming clearer recently is how some HSCs are maintained 
quiescent while others enter self-renewal program. Although bone–lining cells in the 
endosteal surface are often described as osteoblasts in the literature, they are heterogeneous 
in their degree of differentiation, and only a minority of these cells are actually bone 
synthesizing osteoblasts. So a good hypothesis is that in the endosteal niche some cells are in 
contact with true osteoblasts that expresses the necessary factors to maintain quiescence 
while others are not receiving the same signalization so will follow other fate. 
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Li (2008) proposed that HSC quiescence is maintained through several signaling pathways 
including positive and negative regulators from extrinsic and intrinsic factors already 
described. In this context the Tie-2/Ang-1 signaling pathway plays a critical role in the 
maintenance of HSCs in a quiescent state in the bone marrow niche (Adams et al., 2006). 
HSCs express the receptor tyrosine kinase Tie-2 and osteoblasts are the source of the Ang-1 
ligand for Tie-2. Tie-2/Ang-1 signaling activates its key downstream targets, β1-integrin and 
N-cadherin in lineage-negative, Sca-1, C-kit double-positive (LSK), and Tie-2-positive cells, 
and promotes HSC interactions with extracellular matrix and cellular components of the 
niche. This interaction is sufficient to maintain the quiescence and enhanced survival of 
HSCs by preventing cell division (Arai et al., 2007). Ang-1/Tie-2 signaling also activates the 
phosphatidylinositol 3-kinase/Akt signaling pathway (Visnjic et al., 2004). 
Phosphatidylinositol 3-kinase/Akt signaling regulates several cell-cycle regulators, such as 
the CDK inhibitor, p21, which in turn leads to HSC quiescence. 
Other pathway that has been proven to enhance quiescence is TPO/MPL. TPO is secreted 
by osteoblast while MPL is expressed in the membrane of HSCs. Interaction of these two 
proteins maintain HSCs attached to osteoblasts by activation of a pathway that results in the 
expression of their adhesion molecules targets and at the same time activate genetic 
programs which will control entry in cell cycle and survival of HSC. How these positive 
regulators interact with other positive and negative regulators is not completely understood. 
Moreover, which signaling pathways are being activated and which genes have their 
expression changed waits to be clarified. 
A recent study by Wang et al. (2009) recently identified STAT5, a downstream target of 
MPL, as a positive regulator of HSC quiescence by analyzing STAT5−/− mice. Expression of 
quiescence regulators including Tie-2 and p57 are decreased in STAT5−/− HSCs. This 
study demonstrated that STAT5 might mediate MPL effects in maintaining HSC quiescence 
during steady state hematopoiesis and that the same pathway directly or indirectly 
regulates Tie-2 and p57. Interestingly, up-regulation of p57 is essential for TGF-ǃ−induced 
cell-cycle arrest. How these pathways are connected awaits more investigation. 
Two other signaling pathways that act as positive and negative regulators of quiescence 
deserve more discussion, the Hypoxia induced factor (HIF) and Osteopontina signaling 
pathway. Hypoxia microenvironment seems to be important for maintaining HSC 
quiescence The molecular mechanisms for this involve the hypoxia-inducible factor-1a (HIF-
1a) regulated gene expressions in stromal cells. Two genes known to be targets of the HIF 
pathway are c-Kit and stromal cell derived factor−1 (SDF-1 or CXCL12) that both have 
proven to be important to HSC maintenance.  
Osteopontina (OPN) is a negative regulator of HSC quiescence as an OPN-null 
microenvironment is sufficient to increase the number of stem cells associated with 
increased stromal Jagged-1 and Ang-1 expression and reduced primitive hematopoietic cell 
apoptosis. OPN seems to function by preventing HSC cycling. It is interesting to note that 
the release of this inhibition occurs in parallel with the possible activation of the Notch 
pathway. 
As we can see there is many connections between intrinsic factors and extrinsic cues and 
between different intrinsic factors or different extrinsic factors. Some intrinsic factors 
function through affecting extrinsic factors, such as c-Myc, which negatively regulates HSC 
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quiescence by controlling N-cadherin expression level, reducing the N-cadherin−mediated 
interaction between HSCs and niche. Some extrinsic cues function through certain intrinsic 
factors, such as STAT5, which may serve as a component of MPL−induced signaling 
pathway, mediating MPL’s effects in maintaining HSC quiescence. 
Interestingly, among those HSC quiescence regulators that have been identified so far, the 
majority are positive regulators; few are negative for the maintenance of HSCs quiescence. 
This is consistent with the idea showing that the bias toward reduced gene expression that 
actively maintains HSC quiescence is an important mechanism of HSC proliferation, 
suggesting that various positive regulators of HSC quiescence are actively restricting 
proliferation of HSCs, and that there may exist signals in the environment to promote HSC 
proliferation. 
6.2 Deciding for self-renewal 
Many signaling pathways are thought to contribute to stem cell self-renewal in the marrow 
niche including Notch (Maillard et al., 2003), Wnt (Duncan et al. 2005; Reya et al., 2003; 
Willert et al., 2003) and Hedgehog (Baron, 2001 ; Bhardwaj et al., 2001; Gering & Patient 2005). 
Activated Notch expands the stem and progenitor cell compartment by either influencing 
undifferentiated cells to adopt a HSC fate or by causing a G0 HSC population to up-regulate 
runx1-dependent gene expression. Findings that the stem cell markers runx1, scl, and lmo2 
were transcriptionally increased in response to NICD (Notch Intra-Cytoplamatic Domain) 
indicate that stem and progenitor cells were expanded in the adult marrow, possibly by 
increasing stem cell self-renewal. A conditional allele of runx1 was generated in the mouse 
to study the loss of Runx1 function during adult hematopoiesis (Growney et al., 2005; 
Ichikawa et al., 2004). In transplantation studies, Runx1-excised marrow cells showed a 
reduced competitive repopulating ability in long-term engraftment assays (Growney et al., 
2005), demonstrating that Runx1 is essential for normal stem cell function.   
The Wnt/-catenin signaling pathway also plays a crucial role during self-renewal of HSCs 
(Nemeth & Bodine, 2007). Deregulation of this pathway has been implicated in the 
formation of solid tumors, like lung epidermal adenocarcinomas, breast carcinomas and 
intestinal colorectal tumors just to mention a few (Reya & Clevers, 2005). Although several 
Wnt genes are expressed in bone marrow, the precise role of Wnt signaling pathway in 
HSCs and its mechanism(s) of action remained unclear until very recently.  
There is a multitude of Wnt signaling cascades some of them regulating one another. Using 
different receptors, Wnt proteins can trigger at least three intracellular signaling pathways: 
the canonical b-catenin pathway, the non-canonical calcium pathway and the c-Jun N-
terminal kinase pathway (Zeng et al., 2004). Several components of the Wnt signaling 
machinery have been shown to play a role in HSC self-renewal. Both canonical as well as 
non-canonical pathways seem to be involved, since the canonical ligand Wnt3a intrinsically 
promotes self-renewal (Luis et al., 2009). On the other hand, the non-canonical ligand Wnt5a 
has been shown to extrinsically promote self-renewal by inhibiting canonical signaling 
(Murdoch et al., 2003). The mechanistic basis for the balance between canonical and non-
canonical pathways is not fully understood. It is likely that numerous Wnt inhibitors or 
antagonists are modulating Wnt signaling.  
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Taken together, the existing studies suggest that canonical Wnt signaling may not be strictly 
required for HSC function, but that canonical Wnt signaling may affect self-renewal and 
differentiation of HSCs depending on the extent of canonical Wnt signaling and on the 
context of expression of additional genes. Non-canonical Wnt signaling and/or other 
signaling pathways may also compensate for the absence of canonical Wnt signaling in 
maintaining the self-renewal of HSCs (Huang, 2007). 
 To exactly control the fine tune of Wnt in HSC it is likely that the numerous Wnt-signaling 
inhibitors (Dickkopf homolog (Dkk), Wnt inhibitory factor (Wif) or secreted frizzled-related 
protein (Sfrp), or other Wnt antagonists, such as Kremen, Ctgf, Cyr61, Sost and Sostdc1) 
have to be the correctly expressed. Interestingly, some of these molecules also directly 
stimulate certain Fzds independent of Wnt factors. For example, Sfrp1 directly activates 
Fzd2, as well as Fzd4, and Fzd7 but can also interact with Wnt5a (Rodriguez et al., 2005; 
Dufourc et al, 2008; Matsuyama et al, 2009 & Kirstetter et al., 2006). This balance and 
feedback mechanisms between canonical and non-canonical Wnt signaling, suggests that -
catenin is the primary regulatory target of Wnt signaling. However, overexpression or 
stabilization of -catenin results in expansion of the HSC pool, but, at the same time, the loss 
of myelopoiesis is due to a differentiation block (Renstrom et al., 2010), suggesting that b-
catenin promotes self-renewal and/or inhibits differentiation.  
Conversely, Wnt signaling also induces increased expression of HOXB4, Bmi1 and targets of 
Notch-1, genes that are implicated in self-renewal of HSCs . Transcription factors of 
homeodomain family (HOX family) have been found to regulate HSC self-renewal and 
downregulate differentiation. Disruption of HOX genes in mice led to abnormalities in 
multiple hematopoietic cell lineages. Moreover, overexpression of HOX genes (like HOXB4) 
has been associated with HSCs ex vivo expansion and HOX gene mutation with acute 
leukemia.  Bmi1,a polycomb gene, seems to have a repressor role over p16 inhibiting 
apoptosis of HSCs and thus contributing to its maintenance . So the correct Wnt signaling 
seems to be essential to integrate the intracellular response in the decision to self-renew or 
differentiate (Reya et al., 2003). 
The investigation of the interactions between  Bmi1 and Hoxb4, showed that Bmi1 is not 
required for the in vivo expansion of fetal HSCs but is essential for the long-term 
maintenance of adult HSCs. Moreover, Hoxb4 overexpression induces an expansion of 
Bmi1-/- STR-HSCs leading to a rescue of their repopulation defect. Together, these results 
support the emerging concept that fate and sustainability of this fate are two critical 
components of self-renewal in adult stem cells such as HSCs. 
 Moreover Polycomb group (PcG) proteins play a role in the transcriptional repression of genes 
through histone modifications. Recent studies have clearly demonstrated that PcG proteins are 
required for the maintenance of embryonic as well as a broad range of adult stem cells, 
including hematopoietic stem cells (HSCs). PcG proteins maintain the self-renewal capacity of 
HSCs by repressing tumor suppressor genes and keep differentiation programs poised for 
activation in HSCs by repressing a cohort of hematopoietic developmental regulator genes via 
bivalent chromatin domains. Enforced expression of one of the PcG genes, Bmi1, augments the 
self-renewal capacity of HSCs. PcG proteins also maintain redox homeostasis to prevent 
premature loss of HSCs. These findings established PcG proteins as essential regulators of HSCs 
and underscored epigenetics as a new field of HSC research (Li et al., 2010; Komuna, 2010). 
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Recently we demonstrated that another polycomb group member, Suz12 gene, is activated 
by the non canonical Wnt pathway and may epigenetically inhibit genes involved in 
hematopoietic differentiation.  These data pointed to cell cycle changes, deregulation of 
early differentiation genes and regulation of  PRC2 polycomb complex genes, due to Suz12 
role in CML blast crisis. This observation indicates that the cross talk between Wnt and 
Polycomb pathways may promotes hematopoietic differentiation. (Pizzatti et al., 2010). 
Taken together all these data fits in a model were HSCs fated to self renew are in contact in 
the endosteal niches with osteoblasts expressing Notch legands (Jagged) so the pathway that 
will be induced is Notch pathway. 
The Hedgehog (Hh) is a ligand that binds and represses the Patched receptor and thereby 
releases the latent activity of the multipass membrane protein Smoothened, which is 
essential for transducing the Hh signal. Using Patched+/− mouse with increased Hh signaling 
activity, it was demonstrated that constitutive activation of the Hh signaling pathway results 
in the steady-state accumulation of phenotypically defined HSCs and an increase in the 
proportion of cycling cells within this population (Kuhn et al., 1995). However, HSC activity 
on secondary transplantation is reduced 3-fold, indicating the functional exhaustion of the 
HSC pool in this mutant. In vivo treatment with an inhibitor of the Hh pathway rescues 
these transcriptional and functional defects in HSCs. This study establishes Hh  signaling as 
a negative regulator of the HSC quiescence. In contrast to the germline Patched+/− mode, the 
mode of conditional deletion of Smoothened in the adult hematopoietic compartment was 
used in other two studies. However, the negative effects of the Hh pathway on HSC 
quiescence were shown in one study (Walkley & Orkin, 2006) and not in another (Stead et 
al., 2002). The discrepancy is possibly due to a distinct mode of deletion. How this pathway 
collaborate with the two others is not clear although interaction through GSK3 have been 
already proposed.  
The outcome of Hh  signaling varies according to the receiving cell type. GLI, the 
cytoplasmic effector of  Hh  signaling  activates the transcription of several target genes as 
CyclinD1 and D2,N-Myc,Wnts, FoxM1,Hes 1,Bcl2,Osteopontin and others. If these genes are 
activated in HSCs  has not yet been defined but if they are, a clear interconnection between 
several important signaling pathways  is visualized. 
One important point when talking about self-renewal is how to prevent exhaustion of the 
HSC pool. 
7. Role of telomerase in hematopoietic stem cell  
Stem cells self renewal capacity is believed to be closely associated with tissue degeneration 
during aging. Studies of human genetic diseases and gene-targeted animal models have 
provided evidence that functional decline of telomeres and deregulation of cell cycle 
checkpoints contribute to the aging process of tissue stem cells. Telomere dysfunction can 
induce DNA damage response via key cell cycle checkpoints, leading to cellular senescence 
or apoptosis depending on the tissue type and developmental stage of a specific stem cell 
compartment (Ju Z et al., 2011). 
Studies in hematopoietic stem cell (HSC) biology are often focused on “self-renewal” and 
differentiation. Implicit in the word self-renewal is that the two daughter cells generated by 
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a self-renewal division are identical to the parental cell. Strictly speaking, this is not possible 
because DNA is continuously damaged and repaired by DNA-repair mechanisms that are 
not 100% efficient (Lansdorp  et al., 2005). 
It is important to note that the efficiency of DNA repair varies greatly among different stem 
cell types. For example, embryonic stem cells are quite resistant to DNA damage and 
maintain the length of telomere repeats on serial passage, whereas HSCs are quite sensitive 
to DNA damage and less able to maintain telomere length. This idea has given rise to the 
notion that many aspects of normal aging could primarily reflect limitations in DNA repair 
and telomere-maintenance pathways in the (stem) cells of the soma (Lansdorp et al., 2005). 
The loss of telomere repeats in adult hematopoietic cells (including purified “candidate” 
HSCs) relative to fetal hematopoietic cells also fits a model that postulates a finite and 
limited replicative potential of HSCs (Vaziri et al., 1994; Lansdorp et al., 1995;  Lansdorp et 
al., 1997). How this collaborates with the model of LT-HSCs given rise to ST-HSCs has not 
still been addressed. 
Eukaryotic chromosomes are capped by special structures called telomeres, which are 
guanine-rich, simple repeat sequences. Telomeres act to guarantee chromosome integrity by 
preventing illegitimate recombination, degradation, and end fusions (Blackburn et al., 1991; 
Stain et al ., 2004). 
Synthesis and maintenance of telomeric repeats are accomplished by a specialized 
ribonucleoprotein complex known as telomerase. Telomerase consists of an essential RNA 
template and protein components, one of which appears to resemble reverse transcriptase. 
In the absence of telomerase, the failure of DNA polymerase to fully synthesize DNA 
termini leads to chromosome shortening (Stain et al., 2004; Lee et al., 1998).  
In contrast to mice were short telomeres maintain cell survival for some generations, a 
modest two fold reduction in telomerase levels in humans (resulting from 
haploinsufficiency for the telomerase RNA template gene) typically results in premature 
death from complications of aplastic anemia or immune deficiency. Recent studies indicate 
that short telomeres and eventual marrow failure may also result from haploinsufficiency 
for the telomerase reverse transcriptase(hTERT) gene (Yamaguchi et al., 2005). 
Moreover the large number of HSCs typically used in clinical transplant settings may 
effectively prevent their replicative exhaustion. Variations in telomere length between 
cells and individuals have even made it difficult to reproducibly document a decline in 
telomere length following transplantation. Nevertheless, a significant shortening of 
telomeres was observed in the first year after allogeneic bone marrow transplantation 
(Landsdorp et al., 2005). Furthermore, marrow failure with pronounced telomere 
shortening has been described in a few long-term survivors of HSC transplants. Although 
there is little evidence to suggest that telomere shortening will result in an epidemic of 
marrow failure in HSC transplant recipients, caution remains warranted when the cell 
number available for transplantation is limited or when the telomere length in HSCs for 
transplantation is short, as in cells from old donors or patients with telomerase 
deficiencies. It is tempting to speculate that some of the advantages of cord blood HSC 
transplants are related to the longer telomeres in individual cord blood HSCs (Awaya et 
al ., 2002). 
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It has been proposed that telomeres can switch between an open state (in principle allowing 
elongation by telomerase) and a closed state (inaccessible to telomerase) with the likelihood 
of the open state inversely related to the length of the repeat track (Blackburn et al., 2001). In 
most human cells, telomerase appears to be present at limiting levels, allowing elongation of 
only a limited number of critically short telomeres. Accumulation of short telomeres before 
replicative senescence has been observed and replicative senescence or apoptosis could 
result when the number of critically short telomeres exceeds the telomere repair capacity in 
a cell (Ju Z et al., 2011). In this context the ability of HSCs to modulate telomerase activity 
may be crucial in maintaining the self-renewal process. In human BM cells, low telomerase 
activity levels were demonstrated in multipotent HSCs, whereas significant upregulation of 
enzyme activity was apparent in the presence of proliferation-inducing cytokines (Samper et 
al., 2002; Stein et al., 2004). So cytokines and JAK-STAT signaling pathway may contribute to 
self renewal by maintaining telomerase activity. 
The role of DNA repair pathways and telomeres/telomerase in the biology of normal and 
malignant human HSCs cells as well as the biology of aging clearly needs further study. 
New insight in the role of telomerase in HSCs has been provided by recent studies of 
patients with inborn errors in telomerase activity. Therefore, a further understanding of the 
molecular mechanisms underlying HSC aging may help identity new therapeutic targets for 
stem cell-based regenerative medicine. 
8. Asymmetric cell division – A mechanism to generate progenitors while 
maintaining HSC 
In both invertebrates like the insect Drosophila, and mammals, the major characteristic of 
stem cells is their ability to self-renew. Using various modes of proliferation, stem cells 
maintain or expand the available stem cell pool, but they can also generate more specialized 
progeny that constitute the majority of cells in an adult individual. In multi-cellular 
organisms, totipotent zygotes generate pluripotent stem cells, which become increasingly 
restricted in their lineage potential during development, and subsequently give rise to 
mature tissue-specific, multipotent stem cells. Stem cells show either ‘proliferative’ 
symmetric divisions or ‘differentiative’ asymmetric divisions to regulate a balance between 
the maintenance of stem cell pool and the supply of mature cells. It is critical for stem cells 
to tightly control this balance between the two different modes of division, both during 
development and adulthood, because, failure in maintaining cellular homeostasis may lead 
to incomplete tissue or organ development, whereas uncontrolled proliferation can lead to 
tumorigenesis. 
Symmetric cell divisions commonly occur during development of invertebrates and 
vertebrates, phenomena that can also be observed during wound healing and 
regeneration of tissues. This mode of division is defined by the generation of two 
daughter cells that acquire the same fate, thereby expanding the pool of stem cells 
required or generating two differentiating daughter cells. Asymmetric cell divisions play 
a key role in generating cellular diversity during development by generating two 
daughter cells that are committed to different fates in a single division, simultaneously 
self-renewing to generate a daughter cell with stem cell properties, as well as to give rise 
to a more differentiated progeny. 
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Asymmetric stem cell divisions can be controlled by intrinsic mechanisms or the asymmetric 
exposure to extrinsic cues. Intrinsic mechanisms use apical-basal or planar polarity along the 
mitotic spindle to asymmetrically segregate cell fate determinants into only one daughter 
cell. Extrinsic mechanisms rely on contact with the so called stem cell niche, a cellular 
microenvironment that provides external cues (Doe, 2008; Li & Xie, 2005; Morrison & 
Spradling, 2008). Orientation of its mitotic spindle perpendicular to the niche surface allows 
the asymmetric segregation of cell fate determinants relative to the external stimuli to 
maintain self-renewal potential.  
Much progress has been made in understanding intercellular mechanisms, especially the 
identification of niches for various types of tissue stem cells and elucidation of the role of the 
niche in regulating asymmetric stem cell division.  
Although the role of niche in the asymmetric division of mammalian stem cells has not been 
clearly illustrated, Fuchs (2008) have shown that embryonic basal epidermal cells use their 
polarity to divide asymmetrically with respect to the underlying basal lamina, generating a 
committed suprabasal cell and a proliferative basal cell. Because skin stem cells are a 
subpopulation of mitotically active basal epidermal cells, it is conceivable that these stem 
cells divide in an asymmetric fashion to self-renew and to produce differentiated 
keratinocytes. Moreover, integrins and cadherins in the basal lamina are essential for the 
proper localization of apical complexes containing atypical PKC (aPKC), the Par3 – LGN – 
Inscuteable protein, and NuMA (nuclear mitotic apparatus protein) – dynactin. This 
asymmetric localization may be functionally important because similar complexes in 
Drosophila neuroblasts are essential for asymmetric division  (Chia et al., 2008). 
In addition to basal epidermal cells, mouse neuroepithelial stem cells and hematopoietic 
precursor cells undergo both asymmetric and symmetric divisions. In the mammalian 
central nervous system, embryonic neuroepithelial cells first undergo symmetric division to 
expand their population and then switch to asymmetric divisions for neurogenesis. This 
switch involves a change in cleavage plane orientation from perpendicular to parallel to the 
plane of the apical lamina, leading to an asymmetric distribution to the daughter cells of the 
apical plasma membrane, which constitutes only a minute fraction (1 – 2%) of the entire 
neuroepithelial cell plasma membrane (Kosodo et al., 2004). Somewhat similarly, mouse 
hematopoietic progenitor cells are capable of both symmetric and asymmetric divisions in 
cultures supported by stromal cells (Wu et al., 2007). A pro-differentiation stromal cell line 
increased the frequency of asymmetric division, whereas a pro-proliferation stromal cell line 
promoted symmetric division. These observations indicate that niche signaling can also 
control the asymmetry of stem cell division at a populational level. 
Although niche induction accounts for asymmetric division in some types of stem cells, it 
may not play a role in all types of stem cells. In some stem cells there is an intrinsic polarity 
where molecules are segregated along an axis and serves as determinant of cell fate after cell 
division. In these cases the orientation of mitotic spindle has to be coordinated with the 
asymmetric localization of the cell fate regulators. This is the case, for example of Numb 
homologue during hematopoietic precursor cell division. So looking for hematopoietic niche 
and signaling between microenviroment cells and the stem cell we could “ 
envisage”(imagine; idealize, construct) a model for stem cell to decide between symmetric 
or asymmetric division. 
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A particularly exciting development in basic stem cell research in the past few years is the 
discovery of novel functions of cell cycle regulators in controlling the asymmetry of stem 
cell division, as timely reviewed by Chia et al (2008). For example, the cdc2/cdk1 level 
controls whether a neural or muscle progenitor undergoes symmetric or asymmetric 
division. In neuroblasts, high levels of CDK1 during mitosis are required for the asymmetric 
localization of apical and basal protein complexes. In addition, Aurora and Polo kinases act 
as tumor suppressors in neuroblasts by preventing excess self-renewal, implicating the 
function of asymmetric division in restricting over-proliferation. The mutations of these two 
kinase genes affect the asymmetric localization of aPKC, Numb, Partner of Numb, and 
Notch, causing symmetric division to generate two daughter neuroblasts. In addition, 
anaphase-promoting complex/cyclosome is also required for the localization of Miranda 
and its cargo proteins (Prospero, Brain Tumor, and Staufen). More surprisingly, even cyclin 
E, a G1 cyclin, is involved in asymmetric neuroblast division. 
Interestingly in epidermal progenitors the decision of choosing between symmetric cell 
division or asymmetric cell decision is tightly regulated. Two control points have been 
indentified: expression of Inscutable and recruitment of NuMA to the apical cell cortex. 
Moreover in embryonic lung distal epithelium Eya1 protein regulates cell polarity, spindle 
orientation and the localization of Numb, which inhibits Notch signaling with the 
participation of NuMa protein (El-Hashad et al , 2011). 
9. Conclusion 
In the last ten years a body of evidence has accumulated on the hematopoietic stem cell 
niches and the mechanisms by which they regulate HSCs homeostasis. However many 
questions remain to be addressed. What we can speculate with today data is that in the 
endosteal niche dissimilar stages of differentiating osteoblasts provides diverse signals. 
These signals induce a quiescent or a self-renewal fate. However after leaving quiescence 
HSCs are prone to accumulate mutations that will lead to senescence. To prevent HSCs 
exhaustion mechanisms to enhance survival are also induced. Several of these additional 
signals come from the osteoblasts but also from other cells from microenvironment as 
stromal cells and endothelial cells. This is specially visualized in the decision of a symmetric 
or asymmetric division. From the control of all these interconnected pathways depends a 
normal hematopoiesis.  
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